Low-dose stavudine trials: a public health priority for developing countries

The debate around relooking at stavudine dosing, both in terms of the adult low-dose stavudine study and more broadly, is welcome. The study being proposed to evaluate low-dose stavudine v. tenofovir is a fairly standard placebo-controlled non-inferiority study. The study design is not controversial...

Full description

Bibliographic Details
Main Authors: W D Francois Venter, Steve Innes, Mark Cotton
Format: Article
Published: AOSIS 2012-03-01
Series:Southern African Journal of HIV Medicine
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/154